NewBridge Pharmaceuticals is Biotechnology in United Arab Emirates that focus on specialty therapeutics business. Founded in 2007. They cover business area such as developer, specialty therapeutic, device, patient, pharmaceutical, biologic, cancer, diabetes, renal and cardiovascular disease, any critical disease.
2007
( 17 years old in 2024 )
Specialty Therapeutics
-
Business Central Tower A. Floor 18
Dubai Internet City
Dubai United Arab Emirates
Private
developerspecialty therapeuticdevicepatientpharmaceuticalbiologiccancerdiabetesrenal and cardiovascular diseaseany critical disease
* We use standard office opening hours in near NewBridge Pharmaceuticals's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
NewBridge Pharmaceuticals is Biotechnology business from United Arab Emirates that founded in 2007 (17 years old in 2024), NewBridge Pharmaceuticals business is focusing on Specialty Therapeutics.
NewBridge Pharmaceuticals headquarter office and corporate office address is located in Business Central Tower A. Floor 18 Dubai Internet City Dubai United Arab Emirates.
NewBridge Pharmaceuticals was founded in United Arab Emirates.
In 2024, NewBridge Pharmaceuticals is currently focus on specialty therapeutics sector.
Above is snippet of Google Trends for "specialty therapeutics" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with NewBridge Pharmaceuticals, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
